Skip to content

Vincerx Pharma, Inc.: filings

Every Vincerx Pharma, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 22 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2025-05-15fiscal Q1 202530650001193125-25-120762
10-K2025-03-27fiscal FY 202443900001193125-25-065487
10-Q2024-11-12fiscal Q3 2024361010001193125-24-255248
10-Q2024-08-08fiscal Q2 2024361010001193125-24-197025
10-Q2024-05-14fiscal Q1 202439800001193125-24-138276
10-K2024-03-29fiscal FY 202344890001193125-24-081994
10-Q2023-11-14fiscal Q3 2023381050001193125-23-276713
10-Q2023-08-07fiscal Q2 2023381050001193125-23-204428
10-Q2023-05-11fiscal Q1 202337770001193125-23-141993
10-K2023-03-28fiscal FY 202244880001193125-23-082258
10-Q2022-11-10fiscal Q3 2022381050001193125-22-282658
10-Q2022-08-11fiscal Q2 202237990001193125-22-218561
10-Q2022-05-12fiscal Q1 202231630001193125-22-148718
10-K2022-03-29fiscal FY 202137670001193125-22-087454
10-Q2021-11-12fiscal Q3 202130700001193125-21-327128
10-Q2021-08-12fiscal Q2 202128580001193125-21-244689
10-Q2021-05-17fiscal Q1 202126450001193125-21-162642
10-K/A2021-05-14fiscal FY 202026410001193125-21-161167
10-K2021-03-22fiscal FY 202026410001193125-21-089563
10-Q2020-11-10fiscal Q1 202114310001564590-20-052823
10-K2020-09-23fiscal FY 202020360001564590-20-044380
10-Q2020-05-06fiscal Q3 202020490001564590-20-021846

Inspect the source

Entity
Vincerx Pharma, Inc. / CIK 0001796129
Captured
2026-09-21T17:27:47.331Z
SEC response SHA-256
142a50bf55bcc2775b2326af1079ec3bfae6c7bf704f689f5a3f6e796dbb3239

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001796129.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))